To compare the effectiveness of MIDAS and HIT‐6 questionnaires against headache diaries in monitoring treatment response to Erenumab in migraine patients.
Conducted a comparative analysis between questionnaires and headache diaries.
Monitored treatment response to Erenumab in migraine patients.
Utilized the REFORM study design.
Only migraine was validated as a relevant term.
Findings may suggest advantages of using questionnaires for monitoring.